Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05323045
Title A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate BYON3521
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Byondis B.V.

renal cell carcinoma

clear cell renal cell carcinoma

uveal melanoma

Advanced Solid Tumor

head and neck squamous cell carcinoma

papillary renal cell carcinoma



Age Groups: adult | senior
Covered Countries ITA | BEL

No variant requirements are available.